Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

Autor: Javier Benitez, Siegfried Scherneck, Douglas F. Easton, Michael R. Stratton, Christine Maugard, Jocelyne Jacquemier, Suzanne Parry, G Evans, Jenny Varley, Teresa Wagner, Yves-Jean Bignon, L G Fulford, Carolin Nestle-Krämling, Jan G. M. Klijn, Jorge S. Reis-Filho, Fiona Lalloo, Frédérique Penault-Llorca, Rivas C, Marc van der Vijver, Lesley McGuffog, Neva E. Haites, Matthias W. Beckmann, Peter Devilee, Julian Peto, Cees J. Cornelisse, Ute Hamann, Sunil R. Lakhani, Edith Olah, Jenny Chang-Claude, Timothy Bishop, Peter A. Daly, Hanne Meijers-Heijboer, Paolo Radice, Hagay Sobol, Silvana Pilotti, Barry A. Gusterson

Publikováno v: Clinical cancer research, 11(14), 5175-5180. American Association for Cancer Research Inc.
Clinical Cancer Research, 11(14), 5175-5180. American Association for Cancer Research Inc.

Purpose: To investigate the proportion of breast cancers arising in patients with germ line BRCA1 and BRCA2 mutations expressing basal markers and developing predictive tests for identification of high-risk patients. Experimental Design: Histopatholo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::954fc752e5c7e45beab91253ead2308c
https://doi.org/10.1158/1078-0432.CCR-04-2424